SI3169307T1 - Vodni pripravek, ki vsebuje paracetamol in ibuprofen - Google Patents

Vodni pripravek, ki vsebuje paracetamol in ibuprofen

Info

Publication number
SI3169307T1
SI3169307T1 SI201531187T SI201531187T SI3169307T1 SI 3169307 T1 SI3169307 T1 SI 3169307T1 SI 201531187 T SI201531187 T SI 201531187T SI 201531187 T SI201531187 T SI 201531187T SI 3169307 T1 SI3169307 T1 SI 3169307T1
Authority
SI
Slovenia
Prior art keywords
paracetamol
ibuprofen
aqueous formulation
formulation
aqueous
Prior art date
Application number
SI201531187T
Other languages
English (en)
Slovenian (sl)
Inventor
Thomas Jacobsen
Original Assignee
Hyloris Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyloris Pharmaceuticals SA filed Critical Hyloris Pharmaceuticals SA
Publication of SI3169307T1 publication Critical patent/SI3169307T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
SI201531187T 2014-07-18 2015-07-17 Vodni pripravek, ki vsebuje paracetamol in ibuprofen SI3169307T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen
EP15738918.0A EP3169307B1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen
PCT/EP2015/066466 WO2016009067A1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen

Publications (1)

Publication Number Publication Date
SI3169307T1 true SI3169307T1 (sl) 2020-07-31

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531187T SI3169307T1 (sl) 2014-07-18 2015-07-17 Vodni pripravek, ki vsebuje paracetamol in ibuprofen

Country Status (26)

Country Link
US (5) US11219609B2 (da)
EP (2) EP3656377B1 (da)
JP (2) JP6745798B2 (da)
CN (2) CN106794163B (da)
AR (1) AR100365A1 (da)
AU (1) AU2015289035B2 (da)
BR (1) BR112017001093B1 (da)
CA (1) CA2955557C (da)
CY (1) CY1122899T1 (da)
DK (1) DK3169307T3 (da)
EA (1) EA036212B1 (da)
ES (2) ES2791349T3 (da)
HR (1) HRP20200704T1 (da)
HU (1) HUE048881T2 (da)
IL (1) IL250112B2 (da)
LT (1) LT3169307T (da)
MX (1) MX381776B (da)
MY (1) MY192813A (da)
NZ (1) NZ728796A (da)
PL (2) PL3169307T3 (da)
PT (1) PT3169307T (da)
RS (1) RS60289B1 (da)
SG (1) SG11201700421RA (da)
SI (1) SI3169307T1 (da)
TN (1) TN2017000011A1 (da)
WO (2) WO2016008546A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
CN109843266B (zh) * 2016-08-02 2023-08-11 安巴知识产权有限公司 稳定的布洛芬注射组合物
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) * 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
AU2022264500A1 (en) * 2021-04-28 2023-11-09 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Alkali metal salt combinations of incompatible active pharmaceutical ingredients
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法
KR20260020463A (ko) 2023-06-02 2026-02-11 이울리아 츠에티 이부프로펜을 포함하는 약학 조성물
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
GR1011104B (el) * 2024-12-18 2026-01-16 Ιουλια Τσετη Προγεμισμενη συριγγα υδατικου διαλυματος παρακεταμολης καταλληλη για ενεσιμη χορηγηση

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) * 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
WO2009083759A1 (en) 2008-01-03 2009-07-09 Wockhardt Research Centre Oral pharmaceutical suspension comprising paracetamol and ibuprofen
KR20110112279A (ko) * 2008-10-14 2011-10-12 에이에프티 파마슈티칼스 리미티드 의약품 및 치료
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PL2389923T3 (pl) * 2010-05-19 2013-06-28 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia iniekcyjny preparat paracetamolu
LT2635269T (lt) * 2010-11-04 2019-09-10 Aft Pharmaceuticals Limited Derinio kompozicija
BE1020614A5 (nl) 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN104302176B (zh) * 2012-03-16 2017-03-22 坎伯兰医药品股份有限公司 可注射布洛芬制剂
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
ES2791349T3 (es) 2020-11-04
WO2016008546A1 (en) 2016-01-21
BR112017001093B1 (pt) 2023-01-31
HUE048881T2 (hu) 2020-08-28
CN106794163A (zh) 2017-05-31
MX381776B (es) 2025-03-13
CA2955557A1 (en) 2016-01-21
US20250064764A1 (en) 2025-02-27
IL250112B (en) 2022-10-01
PL3656377T3 (pl) 2025-05-26
US11213498B2 (en) 2022-01-04
US11219609B2 (en) 2022-01-11
CN113018258A (zh) 2021-06-25
TN2017000011A1 (en) 2018-07-04
US20190343785A1 (en) 2019-11-14
JP6745798B2 (ja) 2020-08-26
EA036212B1 (ru) 2020-10-14
JP2017522382A (ja) 2017-08-10
EA201790223A1 (ru) 2017-05-31
US20170209398A1 (en) 2017-07-27
EP3169307B1 (en) 2020-02-19
EP3656377C0 (en) 2025-02-12
MY192813A (en) 2022-09-09
AR100365A1 (es) 2016-09-28
AU2015289035A1 (en) 2017-02-23
WO2016009067A1 (en) 2016-01-21
PT3169307T (pt) 2020-05-18
HRP20200704T1 (hr) 2020-07-24
JP6892494B2 (ja) 2021-06-23
RS60289B1 (sr) 2020-07-31
SG11201700421RA (en) 2017-02-27
IL250112B2 (en) 2023-02-01
US20230181502A1 (en) 2023-06-15
CY1122899T1 (el) 2021-05-05
US20220031645A1 (en) 2022-02-03
EP3656377B1 (en) 2025-02-12
US11389416B2 (en) 2022-07-19
CA2955557C (en) 2021-06-22
US12083087B2 (en) 2024-09-10
AU2015289035B2 (en) 2020-03-26
DK3169307T3 (da) 2020-05-11
EP3656377A1 (en) 2020-05-27
LT3169307T (lt) 2020-07-10
IL250112A0 (en) 2017-03-30
CN106794163B (zh) 2021-03-26
EP3169307A1 (en) 2017-05-24
JP2020059740A (ja) 2020-04-16
NZ728796A (en) 2023-05-26
PL3169307T3 (pl) 2020-09-21
MX2017000764A (es) 2017-08-18
ES3013411T3 (en) 2025-04-11
BR112017001093A2 (pt) 2017-11-14

Similar Documents

Publication Publication Date Title
IL252532A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical use
IL250331A0 (en) Flagellin-based agents and uses including effective vaccination
IL250112A0 (en) Aqueous composition containing paracetamol and ibuprofen
EP3106495A4 (en) Nanoparticle-containing solution and use thereof
IL283335B (en) Dihydropyrimidine-2-one compounds and their medical use
IL250729B (en) A pyrazolothiazole compound and a drug containing it
TWI563001B (en) Disintegrin variants and pharmaceutical uses thereof
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
PT3011831T (pt) Limoneno: formulação e utilização inseticida
GB201407384D0 (en) Formulation
DK3145548T3 (en) Aqueous gel composition and its use
PL3429555T3 (pl) Preparat mesny i jego zastosowanie
SG10201501373WA (en) Contrast Agent And Applications Thereof
GB201420805D0 (en) Ligatures and use thereof
SG11201700191PA (en) Microbiocides and uses thereof
GB201513940D0 (en) Catalyst and use thereof
IL255024A0 (en) Hydroxamic acids and their uses
IL252577A0 (en) Preservative-free treprostinil preparations and methods and devices for their use
PL3094338T3 (pl) Oznaczenie i lek
GB2545167B (en) Cloches and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201419354D0 (en) Pharmaceutical extracts and uses thereof